By Kelly Waldron, PhD, Business Unit Manager.

The integration of Artificial Intelligence (AI) into drug manufacturing has the ability to bring substantial improvements to various processes by augmenting human capabilities in several critical ways.

DOWNINGTOWN, Pa. (Jan. 4, 2020) — ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today announced a new corporate
identity, including logo redesign and messaging refinement, as well as the launch of a new website. The refreshed brand and digital presence complement ValSource’s legacy as pioneers in the regulated industry
while providing current and future clients a complete overview of core services and processes.